This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Références
Gage JR (1991) Gait analysis in cerebral palsy clinics. London: Mac Keith Press
Chaléat-Valayer E, Vial C (2002) Mode d’action de la toxine botulique. Spasticité; 4: 17.S
Meunier FA, Schiavo G, Molgo J (2002) Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission. J Physiol Paris; 96(1–2): 105–13
Molenaers G, Desloovere K, Eyssen M, De Cat J, Jonkers I, De Cock P (1999). Botulinum toxin type A treatment of cerebral palsy: an integrated approach. Eur J Neurol; 6(suppl 4): S51–S57
Boyd R, Graham HK (1997) Botulinum toxin A in the management of children with cerebral palsy: indication and outcome. Eur J Neurol; 4(suppl 2): S15–S22
Lee LR, Chuang YC (2004). Botulinum toxin for lower limb spasticity in children with CP a single blinded trial comparing dilution techniques. Am J Phys Med Rehabil; 83(10): 766–73
Boyd RN, Graham HK (1999) Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol; 6(suppl 4): S23–S35
Rodda J, Graham HK (2001) Classification of gait patterns in spastic hemiplegia and spastic diplegia: a basis for a management algorithm. Eur J Neurol; 8(suppl 5): 98–108
Noonan KJ, Halliday S, Browne R et al. (2003) Interobserver variability of gait analysis in patients with cerebral palsy. J Pediatr Orthop; 23(3): 279–87
Lord SE, Halligan PW, Wade DT (1998). Visual gait analysis: the development of a clinical assessment and scale. Clin Rehabil; 12(2): 107–19
Mackey AH, Lobb GL, Walt SE et al. (2003) Reliability and validity of the Observational Gait Scale in children with spastic diplegia. Dev Med Child Neurol; 45(1): 4–11
Boyd RN, Graham H (1999) Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol; 6(suppl 4): S23–S35
Read HS, Hazlewood ME, Hillman SJ et al. (2003) Edinburgh visual gait score for use in cerebral palsy. J Pediatr Orthop; 23(3): 296–301
Chaléat-Valayer E, Bernard JC, Schneider M et al. (2004) Intérêt de l’examen vidéographique dans l’analyse des résultats des injections de toxine botulinique au niveau des membres inférieurs chez l’enfant IMC. Lettre Med Phys Réadapt; (70): 20–2
Morel E, Bernard JC, Chaléat-Valayer E et al. (2004) Injections multisites de toxine botulique chez l’enfant Infirme Moteur Cérébral: rééducation et appareillage (à partir de l’expérience du service enfants du Centre des Massues). Kinésither Ann; (32–33): 28–36
Bell K J, Ounpuu S, DeLuca P et al. (2002) Natural Progression of gait in children with cerebral palsy. J Pediatr Orthop; 22(5): 677–82
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag France, Paris
About this paper
Cite this paper
Chaléat-Valayer, E., Bernard, JC., Morel, É. (2005). Injections de toxine botulique chez l’enfant IMC : stratégie multisites, évaluation multidimensionnelle, prises en charge associées. In: La marche de l’infirme moteur cérébral enfant et adulte. Springer, Paris. https://doi.org/10.1007/2-287-27822-2_5
Download citation
DOI: https://doi.org/10.1007/2-287-27822-2_5
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-25180-1
Online ISBN: 978-2-287-27822-8
eBook Packages: MedicineMedicine (R0)